Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 13 Mar 2023 for Lucira Health, Inc., €33k.
Filing timeline
BuySaleKevin Walter Collins
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Kevin Walter Collins: trading record in brief
Kevin Walter Collins is a declared insider of Lucira Health, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 27 May 2022 to 7 March 2023.
Every open-market trade on record is a sale: 5 sales worth €157k. Since January 2023: no purchases and 2 sales on the market.
The latest filing, published on 13 March 2023, reports an open-market sale of €37k in Lucira Health, Inc. Typically, a trade is published a median of 6 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Walter Collins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
30,102 shares@ US$1.1527.1% of flowCommon StockSEC:0001209191-23-018223:0
9,666 shares@ US$0.423.2% of flowCommon StockSEC:0001209191-22-058925:0
8,580 shares@ US$1.7212.3% of flowCommon StockSEC:0001209191-22-047931:0
37,109 shares@ US$2.0057.4% of flowCommon StockSEC:0001209191-22-041962:0
4 of 4 declarations
